A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
Clinical trial NCT04571385 · COMPLETED
Trial details
- NCT number
- NCT04571385
- Sponsor
- Acesion Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-09
- Primary completion
- 2022-12-13
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.